Victor W. Henderson

Stimulant drug treatment of the attention deficit disorder.

Henderson VW, Southern California Law Review. 1991; 65 (1): 397-409

In school-age children, symptoms of ADD are highly prevalent by nonspecific, and the diagnostic validity of ADD remains unsettled. ADD appears to be a heterogenous nosological designation, often associated with learning disorders and conduct disorders. A genetic predisposition to ADD remains an unproved hypothesis. Brain regions believed to be important in attention are not known to be abnormal in ADD; and mild, nonspecific neurological features, which frequently accompany ADD, are of uncertain significance. Although stimulant drug therapy affecting neurotransmitter systems involved in certain aspects of attention often ameliorates disruptive ADD behaviors, the long-term efficacy of such medical therapy remains controversial.